PCLO.X
Recent Headlines
- PharmaCielo Ltd. Obtains Final Receipt for Short Form Prospectus
- PharmaCielo Welcomes Dr. Claudia Jiménez to Board of Directors
- PharmaCielo Adds Experienced Senior Leader to Executive Team
- These Analysts Just Made An Downgrade To Their PharmaCielo Ltd. (CVE:PCLO) EPS Forecasts
- Analysts Have Lowered Expectations For PharmaCielo Ltd. (CVE:PCLO) After Its Latest Results
- TUESDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against PharmaCielo Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2019
- PharmaCielo Provides Details for Fourth Quarter and Year-End 2019 Results Conference Call
- PharmaCielo Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in PharmaCielo Ltd. to Contact the Firm
- PharmaCielo Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in PharmaCielo Ltd. to Contact the Firm
- When Can We Expect A Profit From PharmaCielo Ltd. (CVE:PCLO)?
- PharmaCielo Ltd. Announces Closing of Previously Announced $8 Million Private Placement Financing
- PCLOF LOSS NOTICE: ROSEN, A TOP FIRM, Reminds PharmaCielo Ltd. Investors with Large Losses of the May 5th Deadline in Class Action Seeking Recovery of Investor Losses - PCLOF
- Shareholder Alert: Robbins LLP Announces It Is Investigating PharmaCielo Ltd. (PCLOF) for Misleading Shareholders
- PharmaCielo Ltd. Prices $8 Million Offering; Closing Scheduled for April 14
- PharmaCielo Ltd. Announces Best Efforts Private Placement Offering
- Shareholder Alert: Robbins LLP Reminds Investors PharmaCielo Ltd. (PCLOF) Sued for Misleading Shareholders
- PHARMACIELO DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In PharmaCielo Ltd. To Contact The Firm
- PharmaCielo Independent Investigation Concludes Short-seller Report Contains Accusations and Claims based on Faulty Interpretation of Events and Information
- PCLOF INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Alerts Investors of Class Action Against PharmaCielo Ltd. and Encourages Investors to Contact the Firm
- Shareholder Alert: Robbins LLP Announces PharmaCielo Ltd. (PCLOF) Sued for Misleading Shareholders
- ROSEN, NATIONAL INVESTOR COUNSEL, Reminds PharmaCielo Ltd. Investors of Important Deadline in Securities Class Action Lawsuit – PCLOF
- (PCLOF) INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Alerts of Class Action Against PharmaCielo Ltd. and Encourages Investors to Contact the Firm
- PHARMACIELO ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against PharmaCielo Ltd. and Encourages Investors to Contact the Firm
- ROSEN, NATIONAL TRIAL COUNSEL, Files Securities Class Action Lawsuit Against PharmaCielo Ltd. - PCLOF
- INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against PharmaCielo Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- PCLOF INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Alerts of Class Action Against PharmaCielo Ltd. and Encourages Investors to Contact the Firm
- INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against PharmaCielo Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- EQUITY ALERT: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Files First Securities Class Action Lawsuit Against PharmaCielo Ltd. – PCLOF
- The Law Offices of Frank R. Cruz Announces Investigation on Behalf of PharmaCielo Ltd. Investors (PCLOF)
- Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of PharmaCielo Ltd. (PCLOF) on Behalf of Investors
- INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against PharmaCielo Ltd. and Encourages Investors with Losses to Contact the Firm
- INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of PharmaCielo Ltd. (PCLOF) on Behalf of Investors
- PCLOF Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Investigation of PharmaCielo Ltd. and Encourages Investors to Contact the Firm
- PharmaCielo Issues Statement Regarding Misleading Short Seller Report
- INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against PharmaCielo Ltd. and Encourages Investors with Losses to Contact the Firm
- EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against PharmaCielo Ltd. – PCLOF
- PharmaCielo Makes Leap Across The Pond With 2 Large-Scale CBD, THC Extracts Sales Agreements
- PharmaCielo Announces 30,000 Kg Cannabis Extract Agreement for German Market
- XPhyto Therapeutics Announces Strategic Supply, Import and Distribution Agreement for the German Cannabis Market
- PharmaCielo Signs Pan-European Distribution Agreement for CBD Isolate and Broad-Spectrum CBD Oil
- PharmaCielo Added to XCAN - the Newly Created S&P/TSX Cannabis Index
- PharmaCielo Becomes First Cultivator Awarded Good Agricultural Practices (GAP) Global Certification for Colombian Medicinal-Cannabis Operations
- PharmaCielo Approved to Export CBD Isolate from Colombia to U.S.
- Those Who Purchased PharmaCielo (CVE:PCLO) Shares A Year Ago Have A 39% Loss To Show For It
- PharmaCielo Receives Acceptance from TSX Venture Exchange of Supply Agreement for Export of 2018 Farm Bill Compliant CBD Isolate to United States
- PharmaCielo Awarded Game-Changer Award by MJDaily
- PharmaCielo Announces Receipt of CAD$3.9 Million Secured Loan Repayment
- OTC Markets Group Welcomes PharmaCielo Ltd. to OTCQX
- PharmaCielo Graduates to OTCQX® Best Market and Secures DTC Eligibility